Full metadata record

DC Field Value Language
dc.contributor.authorKim, YS-
dc.contributor.authorSohn, SY-
dc.contributor.authorYoon, CN-
dc.date.accessioned2024-01-21T07:44:11Z-
dc.date.available2024-01-21T07:44:11Z-
dc.date.created2022-01-25-
dc.date.issued2003-12-
dc.identifier.issn0753-3322-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/138012-
dc.description.abstractThis study was done based on screening test data accumulated from 1994 to 2001 for studying of risk factor related with liver disease and prediction model of liver disease. In the existing study related with liver, the main current is studying on liver cancer, not on liver disease, previous step into liver cancer. As a result of estimating prediction model through the risk factors of liver disease and the growth curve on the basis of data, it is shown that most of the risk factors about liver disease are also those about known well as liver cancer. In addition, to investigate liver disease prevalence from the viewpoint of the future, this study presumed risk factor through the various growth curve analysis and examined logistic regression, decision tree and neural network from those estimators. In the case of neural network using growth curve estimator of X-t(5) = alpha(i) + beta(i)T + epsilon(iT), accuracy of liver disease was 72.55% and sensitivity was 78.62%. On the other hand, in the case of liver disease prediction model using recent screening test data estimator, accuracy was 72.09% and sensitivity was 71.72%. Those are lower than liver disease prediction model of growth curve analysis. In the various liver disease prediction models assumed by growth curve and many distinction models. when growth curve estimator was used, sensitivity value was improved. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER-
dc.titleScreening test data analysis for liver disease prediction model using growth curve-
dc.typeArticle-
dc.identifier.doi10.1016/j.biopha.2003.07.001-
dc.description.journalClass1-
dc.identifier.bibliographicCitationBIOMEDICINE & PHARMACOTHERAPY, v.57, no.10, pp.482 - 488-
dc.citation.titleBIOMEDICINE & PHARMACOTHERAPY-
dc.citation.volume57-
dc.citation.number10-
dc.citation.startPage482-
dc.citation.endPage488-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000187020800007-
dc.identifier.scopusid2-s2.0-0344443273-
dc.relation.journalWebOfScienceCategoryMedicine, Research & Experimental-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalResearchAreaResearch & Experimental Medicine-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusCANCER-
dc.subject.keywordAuthorscreening test-
dc.subject.keywordAuthorliver disease-
dc.subject.keywordAuthorgrowth curve-
dc.subject.keywordAuthorlogistic regression-
dc.subject.keywordAuthordecision tree-
dc.subject.keywordAuthorneural network-
Appears in Collections:
KIST Article > 2003
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE